Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Given

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bioanalysis|March 23, 2011
Biotherapeutic bioanalysis: a multi-indication case study reviewHeather A Myler, Allison Given, Karen Kolz, et al.
The AAPS Journal|September 7, 2014
Next generation ligand binding assays-review of emerging technologies' capabilities to enhance throughput and multiplexingJohanna Mora, Allison Given Chunyk, Mark Dysinger, et al.
Bioanalysis|January 19, 2018
Emerging technologies for biotherapeutic bioanalysis from a high-throughput and multiplexing perspective: insights from an AAPS emerging technology action program committeeShobha Purushothama, Mark Dysinger, Yao Chen, et al.
The AAPS Journal|December 3, 2017
A Multi-site In-depth Evaluation of the Quanterix Simoa from a User's PerspectiveAllison Given Chunyk, Alison Joyce, Saloumeh K Fischer, et al.
Exploratory Research in Clinical and Social Pharmacy|June 4, 2026
Public perceptions and willingness-to-pay regarding over-the-counter (OTC) naloxone: A national cross-sectional survey informed by the Theory of Planned BehaviorAutumn Randles, Emma Tidmore, Kathlyn Smith, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2020
An Optimized Full-Length FLT3/CD3 Bispecific Antibody Demonstrates Potent Anti-leukemia Activity and Reversible Hematological ToxicityYik Andy Yeung, Veena Krishnamoorthy, Danielle Dettling, et al.
The AAPS Journal|July 13, 2016
Feasibility of Singlet Analysis for Ligand Binding Assays: a Retrospective Examination of Data Generated Using the Gyrolab PlatformTracey H Clark, Phillip D Yates, Allison Given Chunyk, et al.
Scientific Reports|February 23, 2019
Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugatesMaria José Costa, Jyothirmayee Kudaravalli, Jing-Tyan Ma, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bioanalysis|March 23, 2011
Biotherapeutic bioanalysis: a multi-indication case study reviewHeather A Myler, Allison Given, Karen Kolz, et al.
The AAPS Journal|September 7, 2014
Next generation ligand binding assays-review of emerging technologies' capabilities to enhance throughput and multiplexingJohanna Mora, Allison Given Chunyk, Mark Dysinger, et al.
Bioanalysis|January 19, 2018
Emerging technologies for biotherapeutic bioanalysis from a high-throughput and multiplexing perspective: insights from an AAPS emerging technology action program committeeShobha Purushothama, Mark Dysinger, Yao Chen, et al.
The AAPS Journal|December 3, 2017
A Multi-site In-depth Evaluation of the Quanterix Simoa from a User's PerspectiveAllison Given Chunyk, Alison Joyce, Saloumeh K Fischer, et al.
Exploratory Research in Clinical and Social Pharmacy|June 4, 2026
Public perceptions and willingness-to-pay regarding over-the-counter (OTC) naloxone: A national cross-sectional survey informed by the Theory of Planned BehaviorAutumn Randles, Emma Tidmore, Kathlyn Smith, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2020
An Optimized Full-Length FLT3/CD3 Bispecific Antibody Demonstrates Potent Anti-leukemia Activity and Reversible Hematological ToxicityYik Andy Yeung, Veena Krishnamoorthy, Danielle Dettling, et al.
The AAPS Journal|July 13, 2016
Feasibility of Singlet Analysis for Ligand Binding Assays: a Retrospective Examination of Data Generated Using the Gyrolab PlatformTracey H Clark, Phillip D Yates, Allison Given Chunyk, et al.
Scientific Reports|February 23, 2019
Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugatesMaria José Costa, Jyothirmayee Kudaravalli, Jing-Tyan Ma, et al.
Pageof 1